Vivera Pharmaceuticals Issues Statement Regarding LuSys Laboratories COVID-19 Tests
/PRNewswire/ -- Vivera Pharmaceuticals is highly discouraged to read the latest FDA safety communication that erroneously lists Vivera Pharmaceuticals as a...
Source: prnewswire.com